GOLDENWELL BIOTECH, INC. (GWLL): auditor change — Goldenwell Biotech dismisses auditor after PCAOB revokes registration; appoints new auditor

GOLDENWELL BIOTECH, INC.

Dismissed Yusufali & Associates on Nov 13, 2024, after PCAOB revoked its registration.
Engaged Michael Gillespie & Associates as new independent auditor on Nov 14, 2024.
Former auditor's reports included going-concern doubt but no adverse opinions or disagreements.
No reportable events or accounting disagreements during the past two fiscal years.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GOLDENWELL BIOTECH, INC. dismissed Yusufali & Associates, LLC as its auditor.

Action: dismissal
Auditor: Yusufali & Associates, LLC

Exact text from the filing

On November 13, 2024, Goldenwell Biotech, Inc. (the “Company”) notified Yusufali & Associates, LLC (“Yusufali & Associates”) that the Company had dismissed Yusufali & Associates as the independent registered public accounting firm of the Company.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GOLDENWELL BIOTECH, INC. engaged Michael Gillespie & Associates, PLLC as its auditor.

Action: engagement
Auditor: Michael Gillespie & Associates, PLLC

Exact text from the filing

On November 14, 2024, the board of directors of the Company resolved to engage the independent registered public accounting firm Michael Gillespie & Associates, PLLC (“Michael Gillespie & Associates”), as the Company’s new independent registered public accountants, which appointment Michael Gillespie & Associates has accepted.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

GOLDENWELL BIOTECH, INC. filing history →

Source: SEC EDGAR

accession 0001477932-24-007310

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.